Should You Buy the SpaceX IPO? Here's What Jim Cramer Thinks

SpaceX has reportedly confidentially filed for an IPO targeting a valuation of $1.75 trillion to $2 trillion, with commentary warning the stock could overshoot to as much as $6 trillion if the float is tightly constrained. The article argues that scarcity, lock-up expirations, and enthusiasm around Musk-linked assets could create distorted price discovery and broader market pressure as mega-cap private names come public. The message is cautionary rather than outright bearish, emphasizing valuation and supply-demand risks over operating fundamentals.

Analysis

The key market variable here is not the headline valuation, but the marginal share available to price discovery. A tightly rationed float in a deal with extreme narrative demand tends to create a reflexive feedback loop: the first post-IPO prints set a reference point, then scarcity plus benchmark and ETF inclusion demand can force incremental buyers to chase irrespective of near-term fundamentals. That is the setup for a short-dated volatility event, not a clean fundamental re-rating.

The second-order effect is cross-asset capital rationing. If this becomes the template for multiple mega-private debuts, capital will be reallocated out of public growth and into primary allocations, creating temporary pressure on other high-duration names with similar investor bases. The more important read-through is to underwriters and late-stage private holders: a successful, high-multiple, low-float launch would encourage more companies to engineer IPO scarcity, which typically enlarges the post-lock-up overhang and increases six-month downside convexity.

For existing public comparables, the most direct beneficiary is not necessarily the obvious space-adjacent names, but anything that can serve as a liquid substitute for exposed growth duration. NVIDIA may see only a sentiment halo rather than a material fundamental read-through; the better trade is on factor rotation and positioning, not on direct business linkage. NASDAQ’s role is subtler: a blockbuster issue improves issuance fees and trading volumes near term, but if the deal crowds out other listings or triggers a broader risk-off rotation, the net effect can wash out quickly.

The consensus is underestimating how fragile the post-IPO price can be once the initial scarcity trade exhausts itself. A small float can inflate the mark for weeks, but lock-up expiry is the real event risk because the market’s clearing price must then absorb insiders, employees, and early holders who have been artificially capped from selling. That creates a classic two-step: momentum first, then supply shock, with the best risk/reward often on faded enthusiasm after the opening week rather than at debut.

Key Decisions for Investors

• Avoid initiating fresh long exposure into the first print; wait 2-6 weeks post-IPO for float expansion and secondary supply to normalize pricing. Best risk/reward is after the opening scarcity premium begins to fade.
• If accessible, buy downside protection on any public-name proxy that rallies on SpaceX halo (especially NVDA) via 3-6 month put spreads; the thesis is not fundamentals deterioration, but multiple compression if growth duration is rotated into the IPO.
• Consider a relative-value trade: long NDAQ / short a basket of high-duration growth names if the IPO wave materially boosts issuance and trading activity. This works only if issuance breadth expands; tighten risk if broader tech weakens beyond the IPO window.
• Set an alert for the 90-180 day lock-up window. That is the highest-conviction short-entry or put-buying window if the stock remains above an obviously stretched level and secondary supply begins to hit.
• If SpaceX prints at a severe scarcity premium, use any first 1-3 week extension to fade with limited-risk structures rather than outright shorting into the squeeze; implied borrow and squeeze risk make defined-risk puts or put spreads superior.